KLCM Advisors Inc. Buys Shares of 13,135 The Clorox Company $CLX

KLCM Advisors Inc. purchased a new position in The Clorox Company (NYSE:CLX) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 13,135 shares of the company’s stock, valued at approximately $1,620,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Canandaigua National Bank & Trust Co. boosted its holdings in Clorox by 0.8% in the third quarter. Canandaigua National Bank & Trust Co. now owns 11,196 shares of the company’s stock worth $1,380,000 after acquiring an additional 94 shares in the last quarter. Fisher Asset Management LLC boosted its stake in Clorox by 1.7% in the 3rd quarter. Fisher Asset Management LLC now owns 6,053 shares of the company’s stock worth $746,000 after purchasing an additional 102 shares in the last quarter. Blue Trust Inc. grew its position in Clorox by 8.5% during the 3rd quarter. Blue Trust Inc. now owns 1,333 shares of the company’s stock valued at $164,000 after purchasing an additional 104 shares during the last quarter. Westhampton Capital LLC increased its stake in Clorox by 0.5% during the 3rd quarter. Westhampton Capital LLC now owns 23,150 shares of the company’s stock valued at $2,854,000 after purchasing an additional 107 shares in the last quarter. Finally, Parvin Asset Management LLC raised its holdings in Clorox by 5.7% in the second quarter. Parvin Asset Management LLC now owns 2,035 shares of the company’s stock worth $244,000 after buying an additional 109 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 3.2%

Clorox stock opened at $112.20 on Thursday. The Clorox Company has a one year low of $96.66 and a one year high of $150.84. The stock has a fifty day moving average of $115.30 and a 200 day moving average of $113.45. The company has a debt-to-equity ratio of 71.03, a quick ratio of 0.48 and a current ratio of 0.74. The stock has a market cap of $13.57 billion, a PE ratio of 18.33, a price-to-earnings-growth ratio of 0.57 and a beta of 0.59.

Clorox (NYSE:CLX) last announced its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a return on equity of 383.01% and a net margin of 11.17%.The firm had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the previous year, the business posted $1.55 earnings per share. The company’s revenue for the quarter was down .8% on a year-over-year basis. As a group, sell-side analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Investors of record on Wednesday, April 22nd will be given a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a yield of 4.4%. The ex-dividend date is Wednesday, April 22nd. Clorox’s payout ratio is 81.05%.

Analyst Ratings Changes

A number of research firms have recently commented on CLX. UBS Group increased their price target on shares of Clorox from $115.00 to $121.00 and gave the company a “neutral” rating in a report on Wednesday, February 4th. Rothschild & Co Redburn set a $117.00 price objective on Clorox in a research report on Friday, February 13th. JPMorgan Chase & Co. boosted their target price on Clorox from $114.00 to $117.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 4th. BNP Paribas Exane upgraded shares of Clorox from an “underperform” rating to a “neutral” rating in a research note on Wednesday, February 11th. Finally, Morgan Stanley raised their price target on shares of Clorox from $125.00 to $136.00 and gave the company an “equal weight” rating in a report on Thursday, February 5th. One equities research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Clorox has a consensus rating of “Reduce” and a consensus price target of $118.73.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.